Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU) Shares Up 6% – Here’s Why

Shares of Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABUGet Free Report) rose 6% during mid-day trading on Monday . The company traded as high as $127.98 and last traded at $127.72. Approximately 207,075 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 2,002,475 shares. The stock had previously closed at $120.47.

Direxion Daily S&P Biotech Bull 3x Shares Stock Performance

The business’s 50 day simple moving average is $130.01 and its 200-day simple moving average is $119.79.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of LABU. McGuire Investment Group LLC raised its holdings in Direxion Daily S&P Biotech Bull 3x Shares by 3.9% during the third quarter. McGuire Investment Group LLC now owns 4,633 shares of the company’s stock valued at $596,000 after buying an additional 175 shares in the last quarter. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at approximately $43,000. Foundations Investment Advisors LLC boosted its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 13.0% during the 3rd quarter. Foundations Investment Advisors LLC now owns 4,617 shares of the company’s stock worth $594,000 after buying an additional 530 shares during the period. Headlands Technologies LLC bought a new stake in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 2nd quarter worth $68,000. Finally, Traynor Capital Management Inc. grew its stake in Direxion Daily S&P Biotech Bull 3x Shares by 6.7% in the 3rd quarter. Traynor Capital Management Inc. now owns 10,763 shares of the company’s stock valued at $1,386,000 after buying an additional 674 shares during the last quarter.

About Direxion Daily S&P Biotech Bull 3x Shares

(Get Free Report)

The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.

Further Reading

Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.